Clinical Trials Directory

Trials / Completed

CompletedNCT01489137

The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation

The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation in the Patients Undergoing Neurosurgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to estimate the EC90 of remifentanil blunting hemodynamic changes to head fixation in the patients undergoing neurosurgery.

Conditions

Interventions

TypeNameDescription
DRUGremifentanilAccording to previous patient's response, the investigators will allocate the effect site concentration of remifentanil of next patient during head fixation. And, For this allocation of dose of remifentanil the investigators use biased coin design up-and-down method. For the first patient, the dose of remifentanil would be fixed at 5.5ng/ml which we predict as EC90. And, step size of dose is 0.5ng/ml.

Timeline

Start date
2011-11-01
Primary completion
2012-02-01
First posted
2011-12-09
Last updated
2012-08-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01489137. Inclusion in this directory is not an endorsement.